Evidence map›Paper›PMID 29331866›Full record

ArticleVirology2018

Development of a novel equine influenza virus live-attenuated vaccine.

Laura Rodriguez, Stephanie Reedy, Aitor Nogales, Pablo R Murcia, Thomas M Chambers, Luis Martinez-Sobrido

Open access · hybridAbstract read
In one paragraph

Article in Virology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Equine Influenza.Cold Spring Harbor perspectives in medicine · 2022
    Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Laura RodriguezDepartment of Microbiology and Immunology, University of Rochester, Rochester, NY, United States.
Stephanie ReedyDepartment of Veterinary Science, Gluck Equine Research Center, University of Kentucky, Lexington, KY, United States.
Aitor NogalesDepartment of Microbiology and Immunology, University of Rochester, Rochester, NY, United States.
Pablo R MurciaMRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.
Thomas M ChambersDepartment of Veterinary Science, Gluck Equine Research Center, University of Kentucky, Lexington, KY, United States.
Luis Martinez-SobridoDepartment of Microbiology and Immunology, University of Rochester, Rochester, NY, United States. Electronic address: luis_martinez@urmc.rochester.edu.
University of Rochester · USUniversity of Kentucky · USMRC University of Glasgow Centre for Virus Research · GB

Funding

Medical Research Council MC_UU_120/14/9Medical Research Council MC_UU_12014/9NIAID NIH HHS HHSN272201400005C
6 · The paper itself

Abstract

H3N8 equine influenza virus (EIV) is an important and significant respiratory pathogen of horses. EIV is enzootic in Europe and North America, mainly due to the suboptimal efficacy of current vaccines. We describe, for the first time, the generation of a temperature sensitive (ts) H3N8 EIV live-attenuated influenza vaccine (LAIV) using reverse-genetics approaches. Our EIV LAIV was attenuated (att) in vivo and able to induce, upon a single intranasal administration, protection against H3N8 EIV wild-type (WT) challenge in both a mouse model and the natural host, the horse. Notably, since our EIV LAIV was generated using reverse genetics, the vaccine can be easily updated against drifting or emerging strains of EIV using the safety backbone of our EIV LAIV as master donor virus (MDV). These results demonstrate the feasibility of implementing a novel EIV LAIV approach for the prevention and control of currently circulating H3N8 EIVs in horse populations.

Indexed as

AnimalsAntibodies, ViralFemaleHorse DiseasesHorsesInfluenza A Virus, H3N8 SubtypeInfluenza VaccinesMaleMiceMice, Inbred C57BLOrthomyxoviridae InfectionsReverse GeneticsVaccinationVaccines, AttenuatedAntibodies, ViralInfluenza VaccinesVaccines, AttenuatedAttenuated (att)Equine influenza virus (EIV)Influenza A virus (IAV)Live-attenuated influenza vaccine (LAIV)Master donor virus (MDV)Reverse genetics techniquesTemperature sensitive (ts)

Identifiers

PMID29331866
PMCPMC5840510
OpenAlexW2783394488

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.